177 related articles for article (PubMed ID: 9349583)
1. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
Radetti G; Persani L; Molinaro G; Mannavola D; Cortelazzi D; Chatterjee VK; Beck-Peccoz P
Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583
[TBL] [Abstract][Full Text] [Related]
2. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.
Anzai R; Adachi M; Sho N; Muroya K; Asakura Y; Onigata K
Thyroid; 2012 Oct; 22(10):1069-75. PubMed ID: 22947347
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis of thyroid hormone resistance.
Asteria C; Rajanayagam O; Collingwood TN; Persani L; Romoli R; Mannavola D; Zamperini P; Buzi F; Ciralli F; Chatterjee VK; Beck-Peccoz P
J Clin Endocrinol Metab; 1999 Feb; 84(2):405-10. PubMed ID: 10022392
[TBL] [Abstract][Full Text] [Related]
4. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).
Guran T; Turan S; Bircan R; Bereket A
J Pediatr Endocrinol Metab; 2009 Oct; 22(10):971-8. PubMed ID: 20020587
[TBL] [Abstract][Full Text] [Related]
5. Association between an R338L mutation in the thyroid hormone receptor-beta gene and thyrotoxic features in two unrelated kindreds with resistance to thyroid hormone.
Menzaghi C; Balsamo A; Di Paola R; Gallone G; Rossi C; Tassi V; Fonzo D; De Filippis V
Thyroid; 1999 Jan; 9(1):1-6. PubMed ID: 10037068
[TBL] [Abstract][Full Text] [Related]
6. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy.
Torre P; Bertoli M; Di Giovanni S; Scommegna S; Conte C; Novelli G; Cianfarani S
J Endocrinol Invest; 2005; 28(7):657-62. PubMed ID: 16218051
[TBL] [Abstract][Full Text] [Related]
7. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
Ueda S; Takamatsu J; Fukata S; Tanaka K; Shimizu N; Sakata S; Yamaji T; Kuma K; Ohsawa N
Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
[TBL] [Abstract][Full Text] [Related]
8. Resistance to thyroid hormone--an uncommon cause of thyroxine excess and inappropriate TSH secretion.
Chatterjee VK
Acta Med Austriaca; 1994; 21(2):56-60. PubMed ID: 7998483
[TBL] [Abstract][Full Text] [Related]
9. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone.
Darendeliler F; Baş F
J Pediatr Endocrinol Metab; 1997; 10(5):535-8. PubMed ID: 9401912
[No Abstract] [Full Text] [Related]
10. The variable clinical phenotype in thyroid hormone resistance syndrome.
Beck-Peccoz P; Chatterjee VK
Thyroid; 1994; 4(2):225-32. PubMed ID: 7920008
[TBL] [Abstract][Full Text] [Related]
11. Genetic analyses and evaluation of peripheral parameters of thyroid hormone action for the differential diagnosis of RTH. A novel heterozygous missense mutation (M334T) discovered.
Mannavola D; Vannucchi G; Fugazzola L; Cerutti N; Persani L; Beck-Peccoz P
J Endocrinol Invest; 2002 Feb; 25(2):RC4-6. PubMed ID: 11929097
[TBL] [Abstract][Full Text] [Related]
12. Resistance to thyroid hormone.
Chatterjee VK
Horm Res; 1997; 48 Suppl 4():43-6. PubMed ID: 9350446
[TBL] [Abstract][Full Text] [Related]
13. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.
Pohlenz J; Weiss RE; Macchia PE; Pannain S; Lau IT; Ho H; Refetoff S
J Clin Endocrinol Metab; 1999 Nov; 84(11):3919-28. PubMed ID: 10566629
[TBL] [Abstract][Full Text] [Related]
14. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes.
Groeneweg S; Peeters RP; Visser TJ; Visser WE
Mol Cell Endocrinol; 2017 Dec; 458():82-90. PubMed ID: 28235578
[TBL] [Abstract][Full Text] [Related]
16. [Thyroid hormone resistance: variable clinical manifestations in five patients].
Reinhardt W; Jockenhövel F; Deuble J; Chatterjee VK; Reinwein D; Mann K
Nuklearmedizin; 1997 Oct; 36(7):250-5. PubMed ID: 9441285
[TBL] [Abstract][Full Text] [Related]
17. The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone.
Safer JD; O'Connor MG; Colan SD; Srinivasan S; Tollin SR; Wondisford FE
J Clin Endocrinol Metab; 1999 Sep; 84(9):3099-109. PubMed ID: 10487671
[TBL] [Abstract][Full Text] [Related]
18. Introducing a point mutation identified in a patient with pituitary resistance to thyroid hormone (Arg 338 to Trp) into other mutant thyroid hormone receptors weakens their dominant negative activities.
Ando S; Nakamura H; Sasaki S; Nishiyama K; Kitahara A; Nagasawa S; Mikami T; Natsume H; Genma R; Yoshimi T
J Endocrinol; 1996 Nov; 151(2):293-300. PubMed ID: 8958790
[TBL] [Abstract][Full Text] [Related]
19. Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone receptor beta gene (P453T).
Wu SY; Sadow PM; Refetoff S; Weiss RE
J Lab Clin Med; 2005 Aug; 146(2):85-94. PubMed ID: 16099238
[TBL] [Abstract][Full Text] [Related]
20. A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up.
Hamon B; Hamon P; Bovier-Lapierre M; Pugeat M; Savagner F; Rodien P; Orgiazzi J
Thyroid; 2008 Jan; 18(1):35-44. PubMed ID: 18302516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
